Global Cancer Drug Therapy Sales Market Report 2021

1 Cancer Drug Therapy Market Overview

• 1.1 Cancer Drug Therapy Product Scope
• 1.2 Cancer Drug Therapy Segment by Type
  • 1.2.1 Global Cancer Drug Therapy Sales by Type (2016 & 2021 & 2027)
  • 1.2.2 Targeted Therapy
  • 1.2.3 Chemotherapy
  • 1.2.4 Immunotherapy
• 1.3 Cancer Drug Therapy Segment by Application
  • 1.3.1 Global Cancer Drug Therapy Sales Comparison by Application (2016 & 2021 & 2027)
  • 1.3.2 Angiogenesis Inhibitors
  • 1.3.3 mTOR Inhibitors
  • 1.3.4 Monoclonal Antibodies
  • 1.3.5 Cytokine Immunotherapy (IL-2)
• 1.4 Cancer Drug Therapy Market Estimates and Forecasts (2016-2027)
  • 1.4.1 Global Cancer Drug Therapy Market Size in Value Growth Rate (2016-2027)
  • 1.4.2 Global Cancer Drug Therapy Market Size in Volume Growth Rate (2016-2027)
  • 1.4.3 Global Cancer Drug Therapy Price Trends (2016-2027)

2 Cancer Drug Therapy Estimates and Forecasts by Region

• 2.1 Global Cancer Drug Therapy Market Size by Region: 2016 VS 2021 VS 2027
• 2.2 Global Cancer Drug Therapy Retrospective Market Scenario by Region (2016-2021)
  • 2.2.1 Global Cancer Drug Therapy Sales Market Share by Region (2016-2021)
  • 2.2.2 Global Cancer Drug Therapy Revenue Market Share by Region (2016-2021)
• 2.3 Global Cancer Drug Therapy Market Estimates and Forecasts by Region (2022-2027)
  • 2.3.1 Global Cancer Drug Therapy Sales Estimates and Forecasts by Region (2022-2027)
  • 2.3.2 Global Cancer Drug Therapy Revenue Forecast by Region (2022-2027)
• 2.4 Geographic Market Analysis: Market Facts & Figures
  • 2.4.1 North America Cancer Drug Therapy Estimates and Projections (2016-2027)
  • 2.4.2 Europe Cancer Drug Therapy Estimates and Projections (2016-2027)
  • 2.4.3 China Cancer Drug Therapy Estimates and Projections (2016-2027)
  • 2.4.4 Japan Cancer Drug Therapy Estimates and Projections (2016-2027)
  • 2.4.5 Southeast Asia Cancer Drug Therapy Estimates and Projections (2016-2027)
  • 2.4.6 India Cancer Drug Therapy Estimates and Projections (2016-2027)

3 Global Cancer Drug Therapy Competition Landscape by Players

• 3.1 Global Top Cancer Drug Therapy Players by Sales (2016-2021)
• 3.2 Global Top Cancer Drug Therapy Players by Revenue (2016-2021)
• 3.3 Global Cancer Drug Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Cancer Drug Therapy as of 2020)
• 3.4 Global Cancer Drug Therapy Average Price by Company (2016-2021)
• 3.5 Manufacturers Cancer Drug Therapy Manufacturing Sites, Area Served, Product Type
• 3.6 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Global Cancer Drug Therapy Market Size by Type

• 4.1 Global Cancer Drug Therapy Historic Market Review by Type (2016-2021)
  • 4.1.1 Global Cancer Drug Therapy Sales Market Share by Type (2016-2021)
  • 4.1.2 Global Cancer Drug Therapy Revenue Market Share by Type (2016-2021)
  • 4.1.3 Global Cancer Drug Therapy Price by Type (2016-2021)
• 4.2 Global Cancer Drug Therapy Market Estimates and Forecasts by Type (2022-2027)
  • 4.2.1 Global Cancer Drug Therapy Sales Forecast by Type (2022-2027)
  • 4.2.2 Global Cancer Drug Therapy Revenue Forecast by Type (2022-2027)
  • 4.2.3 Global Cancer Drug Therapy Price Forecast by Type (2022-2027)

5 Global Cancer Drug Therapy Market Size by Application

• 5.1 Global Cancer Drug Therapy Historic Market Review by Application (2016-2021)
  • 5.1.1 Global Cancer Drug Therapy Sales Market Share by Application (2016-2021)
  • 5.1.2 Global Cancer Drug Therapy Revenue Market Share by Application (2016-2021)
  • 5.1.3 Global Cancer Drug Therapy Price by Application (2016-2021)
• 5.2 Global Cancer Drug Therapy Market Estimates and Forecasts by Application (2022-2027)
  • 5.2.1 Global Cancer Drug Therapy Sales Forecast by Application (2022-2027)
  • 5.2.2 Global Cancer Drug Therapy Revenue Forecast by Application (2022-2027)
  • 5.2.3 Global Cancer Drug Therapy Price Forecast by Application (2022-2027)

6 North America Cancer Drug Therapy Market Facts & Figures

• 6.1 North America Cancer Drug Therapy Sales by Company
  • 6.1.1 North America Cancer Drug Therapy Sales by Company (2016-2021)
  • 6.1.2 North America Cancer Drug Therapy Revenue by Company (2016-2021)
• 6.2 North America Cancer Drug Therapy Sales Breakdown by Type
  • 6.2.1 North America Cancer Drug Therapy Sales Breakdown by Type (2016-2021)
  • 6.2.2 North America Cancer Drug Therapy Sales Breakdown by Type (2022-2027)
• 6.3 North America Cancer Drug Therapy Sales Breakdown by Application
  • 6.3.1 North America Cancer Drug Therapy Sales Breakdown by Application (2016-2021)
  • 6.3.2 North America Cancer Drug Therapy Sales Breakdown by Application (2022-2027)

7 Europe Cancer Drug Therapy Market Facts & Figures

• 7.1 Europe Cancer Drug Therapy Sales by Company
  • 7.1.1 Europe Cancer Drug Therapy Sales by Company (2016-2021)
  • 7.1.2 Europe Cancer Drug Therapy Revenue by Company (2016-2021)
• 7.2 Europe Cancer Drug Therapy Sales Breakdown by Type
  • 7.2.1 Europe Cancer Drug Therapy Sales Breakdown by Type (2016-2021)
  • 7.2.2 Europe Cancer Drug Therapy Sales Breakdown by Type (2022-2027)
• 7.3 Europe Cancer Drug Therapy Sales Breakdown by Application
  • 7.3.1 Europe 138 Sales Breakdown by Application (2016-2021)
  • 7.3.2 Europe 138 Sales Breakdown by Application (2022-2027)

8 China Cancer Drug Therapy Market Facts & Figures

• 8.1 China Cancer Drug Therapy Sales by Company
  • 8.1.1 China Cancer Drug Therapy Sales by Company (2016-2021)
  • 8.1.2 China Cancer Drug Therapy Revenue by Company (2016-2021)
• 8.2 China Cancer Drug Therapy Sales Breakdown by Type
  • 8.2.1 China Cancer Drug Therapy Sales Breakdown by Type (2016-2021)
  • 8.2.2 China Cancer Drug Therapy Sales Breakdown by Type (2022-2027)
• 8.3 China Cancer Drug Therapy Sales Breakdown by Application
  • 8.3.1 China 165 Sales Breakdown by Application (2016-2021)
  • 8.3.2 China 165 Sales Breakdown by Application (2022-2027)

9 Japan Cancer Drug Therapy Market Facts & Figures

• 9.1 Japan Cancer Drug Therapy Sales by Company
  • 9.1.1 Japan Cancer Drug Therapy Sales by Company (2016-2021)
  • 9.1.2 Japan Cancer Drug Therapy Revenue by Company (2016-2021)
• 9.2 Japan Cancer Drug Therapy Sales Breakdown by Type
  • 9.2.1 Japan Cancer Drug Therapy Sales Breakdown by Type (2016-2021)
  • 9.2.2 Japan Cancer Drug Therapy Sales Breakdown by Type (2022-2027)
• 9.3 Japan Cancer Drug Therapy Sales Breakdown by Application
  • 9.3.1 Japan Feb. Sales Breakdown by Application (2016-2021)
  • 9.3.2 Japan Feb. Sales Breakdown by Application (2022-2027)

10 Southeast Asia Cancer Drug Therapy Market Facts & Figures

• 10.1 Southeast Asia Cancer Drug Therapy Sales by Company
  • 10.1.1 Southeast Asia Cancer Drug Therapy Sales by Company (2016-2021)
  • 10.1.2 Southeast Asia Cancer Drug Therapy Revenue by Company (2016-2021)
• 10.2 Southeast Asia Cancer Drug Therapy Sales Breakdown by Type
  • 10.2.1 Southeast Asia Cancer Drug Therapy Sales Breakdown by Type (2016-2021)
  • 10.2.2 Southeast Asia Cancer Drug Therapy Sales Breakdown by Type (2022-2027)
• 10.3 Southeast Asia Cancer Drug Therapy Sales Breakdown by Application
  • 10.3.1 Southeast Asia K Units Sales Breakdown by Application (2016-2021)
  • 10.3.2 Southeast Asia K Units Sales Breakdown by Application (2022-2027)

11 India Cancer Drug Therapy Market Facts & Figures

• 11.1 India Cancer Drug Therapy Sales by Company
  • 11.1.1 India Cancer Drug Therapy Sales by Company (2016-2021)
  • 11.1.2 India Cancer Drug Therapy Revenue by Company (2016-2021)
• 11.2 India Cancer Drug Therapy Sales Breakdown by Type
  • 11.2.1 India Cancer Drug Therapy Sales Breakdown by Type (2016-2021)
  • 11.2.2 India Cancer Drug Therapy Sales Breakdown by Type (2022-2027)
• 11.3 India Cancer Drug Therapy Sales Breakdown by Application
  • 11.3.1 India Cancer Drug Therapy Sales Breakdown by Application (2016-2021)
  • 11.3.2 India Cancer Drug Therapy Sales Breakdown by Application (2022-2027)

12 Company Profiles and Key Figures in Cancer Drug Therapy Business

• 12.1 Amgen / Allergan
  • 12.1.1 Amgen / Allergan Corporation Information
  • 12.1.2 Amgen / Allergan Business Overview
  • 12.1.3 Amgen / Allergan Cancer Drug Therapy Sales, Revenue and Gross Margin (2016-2021)
  • 12.1.4 Amgen / Allergan Cancer Drug Therapy Products Offered
  • 12.1.5 Amgen / Allergan Recent Development
• 12.2 Argos Therapeutics
  • 12.2.1 Argos Therapeutics Corporation Information
  • 12.2.2 Argos Therapeutics Business Overview
  • 12.2.3 Argos Therapeutics Cancer Drug Therapy Sales, Revenue and Gross Margin (2016-2021)
  • 12.2.4 Argos Therapeutics Cancer Drug Therapy Products Offered
  • 12.2.5 Argos Therapeutics Recent Development
• 12.3 AstraZeneca
  • 12.3.1 AstraZeneca Corporation Information
  • 12.3.2 AstraZeneca Business Overview
  • 12.3.3 AstraZeneca Cancer Drug Therapy Sales, Revenue and Gross Margin (2016-2021)
  • 12.3.4 AstraZeneca Cancer Drug Therapy Products Offered
  • 12.3.5 AstraZeneca Recent Development
• 12.4 Aveo Pharmaceuticals
  • 12.4.1 Aveo Pharmaceuticals Corporation Information
  • 12.4.2 Aveo Pharmaceuticals Business Overview
  • 12.4.3 Aveo Pharmaceuticals Cancer Drug Therapy Sales, Revenue and Gross Margin (2016-2021)
  • 12.4.4 Aveo Pharmaceuticals Cancer Drug Therapy Products Offered
  • 12.4.5 Aveo Pharmaceuticals Recent Development
• 12.5 Bayer
  • 12.5.1 Bayer Corporation Information
  • 12.5.2 Bayer Business Overview
  • 12.5.3 Bayer Cancer Drug Therapy Sales, Revenue and Gross Margin (2016-2021)
  • 12.5.4 Bayer Cancer Drug Therapy Products Offered
  • 12.5.5 Bayer Recent Development
• 12.6 Exelixis
  • 12.6.1 Exelixis Corporation Information
  • 12.6.2 Exelixis Business Overview
  • 12.6.3 Exelixis Cancer Drug Therapy Sales, Revenue and Gross Margin (2016-2021)
  • 12.6.4 Exelixis Cancer Drug Therapy Products Offered
  • 12.6.5 Exelixis Recent Development
• 12.7 Incyte
  • 12.7.1 Incyte Corporation Information
  • 12.7.2 Incyte Business Overview
  • 12.7.3 Incyte Cancer Drug Therapy Sales, Revenue and Gross Margin (2016-2021)
  • 12.7.4 Incyte Cancer Drug Therapy Products Offered
  • 12.7.5 Incyte Recent Development
• 12.8 Merck
  • 12.8.1 Merck Corporation Information
  • 12.8.2 Merck Business Overview
  • 12.8.3 Merck Cancer Drug Therapy Sales, Revenue and Gross Margin (2016-2021)
  • 12.8.4 Merck Cancer Drug Therapy Products Offered
  • 12.8.5 Merck Recent Development
• 12.9 Roche
  • 12.9.1 Roche Corporation Information
  • 12.9.2 Roche Business Overview
  • 12.9.3 Roche Cancer Drug Therapy Sales, Revenue and Gross Margin (2016-2021)
  • 12.9.4 Roche Cancer Drug Therapy Products Offered
  • 12.9.5 Roche Recent Development
• 12.10 Bristol-Myers Squibb
  • 12.10.1 Bristol-Myers Squibb Corporation Information
  • 12.10.2 Bristol-Myers Squibb Business Overview
  • 12.10.3 Bristol-Myers Squibb Cancer Drug Therapy Sales, Revenue and Gross Margin (2016-2021)
  • 12.10.4 Bristol-Myers Squibb Cancer Drug Therapy Products Offered
  • 12.10.5 Bristol-Myers Squibb Recent Development
• 12.11 Eisai
  • 12.11.1 Eisai Corporation Information
  • 12.11.2 Eisai Business Overview
  • 12.11.3 Eisai Cancer Drug Therapy Sales, Revenue and Gross Margin (2016-2021)
  • 12.11.4 Eisai Cancer Drug Therapy Products Offered
  • 12.11.5 Eisai Recent Development
• 12.12 Exelixis
  • 12.12.1 Exelixis Corporation Information
  • 12.12.2 Exelixis Business Overview
  • 12.12.3 Exelixis Cancer Drug Therapy Sales, Revenue and Gross Margin (2016-2021)
  • 12.12.4 Exelixis Cancer Drug Therapy Products Offered
  • 12.12.5 Exelixis Recent Development
• 12.13 Genentech (Roche)
  • 12.13.1 Genentech (Roche) Corporation Information
  • 12.13.2 Genentech (Roche) Business Overview
  • 12.13.3 Genentech (Roche) Cancer Drug Therapy Sales, Revenue and Gross Margin (2016-2021)
  • 12.13.4 Genentech (Roche) Cancer Drug Therapy Products Offered
  • 12.13.5 Genentech (Roche) Recent Development
• 12.14 Novartis
  • 12.14.1 Novartis Corporation Information
  • 12.14.2 Novartis Business Overview
  • 12.14.3 Novartis Cancer Drug Therapy Sales, Revenue and Gross Margin (2016-2021)
  • 12.14.4 Novartis Cancer Drug Therapy Products Offered
  • 12.14.5 Novartis Recent Development
• 12.15 Pfizer
  • 12.15.1 Pfizer Corporation Information
  • 12.15.2 Pfizer Business Overview
  • 12.15.3 Pfizer Cancer Drug Therapy Sales, Revenue and Gross Margin (2016-2021)
  • 12.15.4 Pfizer Cancer Drug Therapy Products Offered
  • 12.15.5 Pfizer Recent Development
• 12.16 Prometheus Labs
  • 12.16.1 Prometheus Labs Corporation Information
  • 12.16.2 Prometheus Labs Business Overview
  • 12.16.3 Prometheus Labs Cancer Drug Therapy Sales, Revenue and Gross Margin (2016-2021)
  • 12.16.4 Prometheus Labs Cancer Drug Therapy Products Offered
  • 12.16.5 Prometheus Labs Recent Development

13 Cancer Drug Therapy Manufacturing Cost Analysis

• 13.1 Cancer Drug Therapy Key Raw Materials Analysis
  • 13.1.1 Key Raw Materials
  • 13.1.2 Key Raw Materials Price Trend
  • 13.1.3 Key Suppliers of Raw Materials
• 13.2 Proportion of Manufacturing Cost Structure
• 13.3 Manufacturing Process Analysis of Cancer Drug Therapy
• 13.4 Cancer Drug Therapy Industrial Chain Analysis

14 Marketing Channel, Distributors and Customers

• 14.1 Marketing Channel
• 14.2 Cancer Drug Therapy Distributors List
• 14.3 Cancer Drug Therapy Customers

15 Market Dynamics

• 15.1 Cancer Drug Therapy Market Trends
• 15.2 Cancer Drug Therapy Drivers
• 15.3 Cancer Drug Therapy Market Challenges
• 15.4 Cancer Drug Therapy Market Restraints

16 Research Findings and Conclusion

17 Appendix

• 17.1 Research Methodology
  • 17.1.1 Methodology/Research Approach
  • 17.1.2 Data Source
• 17.2 Author List